Skip to main content

Quipt Home Medical Agrees to Acquisition by Kingswood

Tipranks - Tue Dec 16, 2025

Claim 50% Off TipRanks Premium and Invest with Confidence

Quipt Home Medical ( (TSE:QIPT) ) just unveiled an announcement.

On December 14, 2025, Quipt Home Medical Corp. entered into an agreement to be acquired by 1567208 B.C. LTD and REM Aggregator, LLC, entities affiliated with Kingswood Capital Management. The acquisition, approved by Quipt’s board, involves purchasing all outstanding shares at $3.65 per share, with plans to delist from major stock exchanges. The transaction is expected to close in the first half of 2026, pending shareholder and court approvals, among other conditions.

The most recent analyst rating on (TSE:QIPT) stock is a Hold with a C$3.50 price target. To see the full list of analyst forecasts on Quipt Home Medical stock, see the TSE:QIPT Stock Forecast page.

Spark’s Take on TSE:QIPT Stock

According to Spark, TipRanks’ AI Analyst, TSE:QIPT is a Neutral.

Quipt Home Medical’s overall stock score is primarily impacted by its financial performance, which shows profitability challenges despite strong cost management. The technical analysis indicates bearish momentum, and the valuation is negatively affected by the company’s unprofitability. The earnings call provided some positive insights into strategic growth and stable EBITDA margins, but ongoing challenges remain.

To see Spark’s full report on TSE:QIPT stock, click here.

More about Quipt Home Medical

Quipt Home Medical Corp. is a company based in British Columbia that operates in the healthcare industry, focusing on providing home medical equipment and services.

Average Trading Volume: 16,945

Technical Sentiment Signal: Sell

Current Market Cap: C$156.4M

Find detailed analytics on QIPT stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.
This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.